Excited to announce I've matched to Memorial Sloan Kettering Cancer Center for oncology fellowship, and feeling super grateful for all the support I've had throughout my various life stages. To celebrate, here's a pic of Conrad practicing his big-city mean mug look #HemeOnc #match #mdphd #doubledocs

We are thrilled to announce the Hematology/Oncology fellows who will be joining MSK in July 2025! We can't wait to welcome these talented trainees. Memorial Sloan Kettering Cancer Center #Match2024

In ‘21 I left Harvard when my lab was growing quickly, I was an NIH Director DP5 Recipient, millions in grant funding and papers in top journals But pandemic put grants/publishing into new perspective Here’s a new interview covering *some* of why I left harvardmagazine.com/2025/01/harvar…

🔹MD-PhDs had a lower lifetime earning potential than MDs 🔹Inverse relationship between earning potential and research effort 🔹MD-PhDs in high-earning specialties tending to spend less time on research Journal of Clinical Investigation insight.jci.org/articles/view/…

Happy Holidays from our Longcope family to yours🎄 The Osler Medical Residency

No study section...no grant reviews No grant reviews...no grants awarded No grants awarded...no research No research...no functional NIH And if your salary was funded by NIH, no paycheck either if this lasts indefinitely

1) Since there is a lot of confusion about the reduction of the overhead rate on NIH grants to 15% (see here: grants.nih.gov/grants/guide/n…) I'll do a little tweetorial (or X-torial?) about it.

This kills biomedical research

A “largest” R01 is now capped at 575k/year incl 15% indirect. NIH CUTS total 4 BILLION dollars/year So that SHOULD mean 7000 more grants/yr? Twice the current # of R01s. BUT THEN WHY NOT MENTION in the NIH statement? BECAUSE THE PLAN IS JUST TO CUT, NOT TO DO MORE RESEARCH.

This was one of RFK Jr.’s first orders after being sworn in. Just an astonishing denial of science and will cause so much pain to the 45 million Americans facing mental health challenges.

I’m just a millennial… …standing in front of the U.S. economy… …asking it not to crash… …for the third time in my life.

Thrilled to welcome the next generation of Oslerian physicians — welcome to the Osler Medical Residency and the Osler family! We cannot wait to have you join us #oslerpride

thebaltimorebanner.com/economy/scienc…

As a Jewish student at Harvard, I can tell you first-hand that cutting cancer research doesn’t do anything about antisemitism. It’s clear that antisemitism is a cover for the Trump administration’s dangerous agenda of attacking institutions of learning and critical research.

Leenus Martin Plexium shares details of their CDK2 CRBN-engaging molecular glue degrader program (in pre-candidate LO stage) at #AACR25 AACR. Targeting cyclinE amplified tumors, interesting early data comparing to CDK2 inhibitors.

It is disappointing & very concerning to read there may be a purposeful delay in appointing an NCI Director to strongly advocate for preserving and enhancing National Cancer Institute’s vital role in the war on cancer. It’s too important. Association of American Cancer Institutes ASCO American Cancer Society AACR Jay Bhattacharya, MD, PhD

‘Soul crushing’: What’s at stake for defunded NYC researchers and their projects? - Gothamist gothamist.com/news/soul-crus…

“One of the biggest tragedies I've observed in my professional life.” David R. Liu, winner of the Breakthrough in Life Sciences and professor at the Broad Institute and Harvard University, describes the cost of government cuts to science research at universities. Walter Isaacson

US self-reported race and ethnicity are poor proxies of genetic ancestry, researchers say. cell.com/ajhg/fulltext/… Learn more in AJHG

“From 2020 to 2024, universities contributed patents underpinning 50% of U.S. FDA-approved drugs. Even more stunningly, 87% of those academic breakthroughs came from American institutions.” statnews.com/2025/06/06/us-… via STAT